Ber-ACT8:_new_monoclonal_antibody_to_the_mucosa_lymphocyte_antigen._Using_a_newly_established_HTLV-1_positive_T_cell_line_as_an_immunogen,_a_new_monoclonal_antibody,_Ber-ACT8,_was_produced._It_reacts_with_in_vitro_activated_T_cells_and_a_small_subset_of_normal_resting_T_cells,_but_not_with_resting_B_cells_or_any_of_the_29_established_human_permanent_cell_lines_tested._Immunohistological_analysis_of_a_wide_spectrum_of_human_tissues_showed_that_Ber-ACT8_reactivity_is_restricted_to_a_few_T_cells_in_the_peripheral_blood,_the_extrafollicular_areas_of_lymph_nodes_and_tonsils,_and_splenic_red_pulp._In_the_gut_Ber-ACT8_labelled_most_intraepithelial_T_cells_and_up_to_50%_of_lamina_propria_T_cells._The_antibody_also_immunostained_T_cells_present_in_the_oral_and_bronchial_mucosa._Double_labelling_on_splenic_cells,_fresh_blood_lymphocytes,_and_in_vitro_activated_T_cells_showed_that_most_Ber-ACT8_positive_cells_coexpressed_CD8._Ber-ACT8_did_not_react_with_any_of_the_14_Hodgkin's_lymphomas_nor_any_of_the_172_non-Hodgkin's_lymphomas_tested,_with_the_exception_of_10_cases_of_T_cell_lymphomas,_five_of_which_were_located_in_the_jejunum_and_associated_with_coeliac_disease,_and_one_B_cell_lymphoma,_and_most_cases_of_hairy_cell_leukaemia_tested._Parallel_immunostainings_with_Ber-ACT8,_anti-TCR-beta_(beta_F1),_and_anti-TCR-delta_showed_that_most_Ber-ACT8_positive_T_cells_carry_the_TCR_of_alpha_beta_type._Comparison_of_Ber-ACT8_with_HML-1,_B-ly7,_and_LF61_showed_essentially_the_same_reactivity_and_an_identical_molecular_target._The_molecular_structure_recognised_seems_to_be_a_trimeric_molecule_with_components_of_150,_125_and_105_kilodaltons,_with_the_Ber-ACT8_epitope_localised_on_the_150_kilodalton_chain._The_150_kilodalton_molecule_contains_an_0-linked_carbohydrate_moiety_of_about_10_kilodaltons._Because_of_its_very_selective_distribution,_the_trimeric_antigen_is_a_powerful_reagent_for_the_diagnosis_of_gut_T_cell-derived_T_cell_lymphomas_and_other_extranodal_T_cell_lymphomas,_as_well_as_hairy_cell_leukaemia.